# DEVELOPMENT OF BROAD SPECTRUM ANTIVIRALS

> **NIH NIH N01** · UNITHER VIROLOGY, LLC · 2021 · $1,219,399

## Abstract

This contract supports the advanced development of promising biodefense therapeutic candidates/products with broad spectrum activity. The research and development activities supported will allow candidate therapeutic countermeasures to progress through the product development pipeline, and includes preclinical/non-clinical and clinical IND development activities.

## Key facts

- **NIH application ID:** 10428339
- **Project number:** 272201100030C-P00031-9999-1
- **Recipient organization:** UNITHER VIROLOGY, LLC
- **Principal Investigator:** MATTHEW DUCHARS
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $1,219,399
- **Award type:** —
- **Project period:** 2011-09-27 → 2021-06-07

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10428339

## Citation

> US National Institutes of Health, RePORTER application 10428339, DEVELOPMENT OF BROAD SPECTRUM ANTIVIRALS (272201100030C-P00031-9999-1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10428339. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*